FindTrial
Sign In

Efficacy and safety of hypotensive anesthesia on reducing perioperative blood loss in simultaneous bilateral total hip arthroplasty

Efficacy and safety of hypotensive anesthesia on reducing perioperative blood loss in simultaneous bilateral total hip arthroplasty

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047184
Enrollment
Unknown
Registered
2021-06-10
Start date
2021-06-09
Completion date
Unknown
Last updated
2022-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End-stage hip disease

Interventions

Intraoperative MAP 70 - 80 mmHg:Nil
Intraoperative MAP < 70 mmHg:Nil
Control group:Nilsson

Sponsors

West China Hospital, Sichuan Univercity
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Aged >= 18 years, regardless of gender; 2.Patients underwent simultaneous bilateral total hip arthroplasty for the treatment of end-stage hip diseases; 3.American Society of Anesthesiologists (ASA) grade was i-iii grade ; 4.Tranexamic acid administrated.

Exclusion criteria

Exclusion criteria: 1.Patients with cerebrovascular accident and neuropathy; 2.Patients with cardiopulmonary disease and hepatorenal disfunction; 3.Patients with severe anemia, hypovolemia, and coagulation disorders; 4.Patients with refactory hypertension and peripheral vascular diseases.

Design outcomes

Primary

MeasureTime frame
Total blood loss;Dominant blood loss;Hidden blood loss;Transfusion rate;Transfusion volume;Complications;—

Secondary

MeasureTime frame
Duration of surgery/anesthesia;—

Countries

China

Contacts

Public ContactZeng Yi

West China Hospital, Sichuan Univercity

zengyigd@126.com+86 18980602289

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026